Recently added articles from Clinical Trials Week:
Study confirms that cannabis is beneficial for multiple sclerosis.
Dec 21, 2009 ... Cannabis can reduce spasticity in multiple sclerosis (MS) patients. A systematic review, published in the open access journal BMC Neurology, found that five out six randomized controlled trials reported a reduction in spasticity and an improvement in mobility (see also BioMed Central). ...
Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy.(Clinical report)
Dec 21, 2009 ... Data published online in the medical journal Muscle and Nerve support the use of the six-minute walk test (6MWT) as an outcome measure in PTC Therapeutics, Inc.'s ongoing registration-directed clinical trial of ataluren in patients with nonsense mutation Duchenne/Becker muscular dystrophy ...
Scripps research team restores some function to cells from cystic fibrosis patients.
Dec 21, 2009 ... In an encouraging new development, a team led by Scripps Research Institute scientists has restored partial function to lung cells collected from patients with cystic fibrosis. While there is still much work to be done before the therapy can be tested in humans, the discovery opens the ...
$100,000 Grant Awarded for Potential Treatment of FXS Cognitive Deficits.
Dec 21, 2009 ... The National Fragile X Foundation has awarded a translational research seed grant of $100,000 to Dr. Randi J. Hagerman at the UC Davis M.I.N.D. Institute in California for a study of minocycline in the treatment of children with fragile X syndrome (FXS). Hagerman is an internationally ...
Successful Stem Cell Therapy for Treatment of Eye Disease.
Dec 21, 2009 ... Newly published research, by investigators, at the North East England Stem Cell Institute (NESCI) in the journal STEM CELLS reported the first successful treatment of eight patients with "Limbal Stem Cell Deficiency" (LSCD) using the patients' own stem cells without the need of suppressing ...